RCA
PFE icon

Ranch Capital Advisors’s Pfizer PFE Stock Holding History

Ranch Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
85,339
+7,343
+9% +$192K 0.65% 53
2026
Q1 		$2.19M Buy
77,996
+3,966
+5% +$106K 0.79% 44
2025
Q4 		$1.84M Buy
74,030
+4,079
+6% +$103K 0.68% 47
2025
Q3 		$1.78M Buy
69,951
+57,162
+447% +$1.41M 0.69% 47
2025
Q2 		$310K Sell
12,789
-515
-4% -$12K 0.13% 121
2025
Q1 		$337K Buy
13,304
+325
+3% +$8.5K 0.16% 116
2024
Q4 		$344K Sell
12,979
-447
-3% -$12.1K 0.16% 115
2024
Q3 		$389K Buy
13,426
+468
+4% +$13.7K 0.18% 110
2024
Q2 		$363K Sell
12,958
-310
-2% -$8.54K 0.19% 113
2024
Q1 		$368K Sell
13,268
-648
-5% -$18K 0.2% 113
2023
Q4 		$401K Sell
13,916
-521
-4% -$15.8K 0.25% 107
2023
Q3 		$479K Sell
14,437
-1,163
-7% -$41.1K 0.34% 89
2023
Q2 		$572K Sell
15,600
-787
-5% -$30.6K 0.4% 79
2023
Q1 		$669K Sell
16,387
-3,180
-16% -$137K 0.49% 64
2022
Q4 		$1M Sell
19,567
-232
-1% -$11.1K 0.78% 37
2022
Q3 		$866K Sell
19,799
-897
-4% -$43.6K 0.71% 45
2022
Q2 		$1.08M Sell
20,696
-87
-0.4% -$4.43K 0.83% 40
2022
Q1 		$1.08M Sell
20,783
-990
-5% -$51.4K 0.71% 42
2021
Q4 		$1.29M Sell
21,773
-282
-1% -$14K 0.84% 38
2021
Q3 		$949K Sell
22,055
-468
-2% -$20.7K 0.59% 48
2021
Q2 		$882K Buy
22,523
+123
+0.5% +$4.78K 0.53% 57
2021
Q1 		$811K Sell
22,400
-1,397
-6% -$49.6K 0.54% 56
2020
Q4 		$875K Sell
23,797
-369
-2% -$13.5K 0.63% 43
2020
Q3 		$858K Sell
24,166
-469
-2% -$16.4K 0.69% 36
2020
Q2 		$897K Sell
24,635
-509
-2% -$17.3K 0.7% 35
2020
Q1 		$778K Sell
25,144
-2,742
-10% -$93.4K 0.77% 26
2019
Q4 		$1.04M Sell
27,886
-2,483
-8% -$88.4K 0.84% 19
2019
Q3 		$1.03M Buy
+30,369
New +$1.1M 1.11% 16

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ranch Capital Advisors's PFE Position: Q2 2026 in Review

Ranch Capital Advisors increased its Pfizer (PFE) stake by 9.4% in Q2 2026, buying an estimated $192K and bringing the position to 85,339 shares worth $2.05M. The position accounts for 0.65% of the portfolio, ranked #53.

Ranch Capital Advisors first reported a position in PFE in Q3 2019 and has held it in 28 quarters since. The position peaked at $2.19M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ranch Capital Advisors held 85,339 shares of Pfizer worth $2.05M as of Q2 2026.
  • Ranch Capital Advisors bought 7,343 Pfizer shares in Q2 2026, an estimated $192K.
  • Pfizer made up 0.65% of Ranch Capital Advisors's portfolio in Q2 2026, its #53 holding.
  • Ranch Capital Advisors first reported a position in Pfizer in Q3 2019 and has held it in 28 quarters since.
  • Ranch Capital Advisors's Pfizer position peaked at $2.19M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ranch Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.